πŸ‡ΊπŸ‡Έ FDA
Patent

US 9540330

Oligomer-containing hydantoin compounds

granted A61KA61K47/60A61P

Quick answer

US patent 9540330 (Oligomer-containing hydantoin compounds) held by Nektar Therapeutics expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/60, A61P, A61P25/08